Thursday, November 8, 2012
A Harvard Medical School and Tsinghua University team has
developed a technology, dubbed MuSIC, that identifies synergistic drug pairs.1
The group showed proof of concept by finding new combinations of therapeutics
for HIV, but weeding out false negatives could prove challenging.
T. SciBX 5(44);
Published online Nov. 8, 2012
1. Tan, X. et al. Nat.
Biotechnol.; published online Oct. 14, 2012; doi:10.1038/nbt.2391
Contact: Stephen J. Elledge, Harvard Medical School and Brigham and
Women's Hospital, Boston, Mass.
2. Douek, D.C. et al.
Annu. Rev. Med. 60, 471-484 (2009)
AND INSTITUTIONS MENTIONED
Boston University, Boston, Mass.
Columbia University, New York, N.Y.
Harvard Medical School, Boston, Mass.
Merrimack Pharmaceuticals Inc. (NASDAQ:MACK), Cambridge, Mass.
National University of Singapore, Singapore
Novartis Institutes for BioMedical Research, Cambridge, Mass.
Third Rock Ventures, Boston, Mass.
Tsinghua University, Beijing, China
Zalicus Inc. (NASDAQ:ZLCS), Cambridge, Mass.